Ebol, Gregorio M.
HRN: 24-38-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2024
02/26/2024
IV
600
Q6
Infected CTT Site
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes